Biological activity of hemoglobin-containing complex isolated from blood serum of mice with Ehrlich carcinoma

Area of Science:

• Oncology
• Biochemistry
• Immunology

Background:

• Ehrlich carcinoma is a widely studied murine tumor model.
• Serum protein complexes have potential therapeutic applications.
• Understanding tumor-host interactions is crucial for cancer treatment.

Purpose of the Study:

• To investigate the anti-tumor effects of a hemoglobin-containing serum protein complex.
• To determine the impact of this complex on Ehrlich carcinoma cell cycle and apoptosis.
• To explore the direct effects of the complex on tumor cells in vitro.

Main Methods:

• Isolation of hemoglobin-containing serum protein complex from tumor-bearing animals.
• Intraperitoneal and intramuscular transplantation of Ehrlich carcinoma in C57Bl/6 mice.
• Analysis of tumor cell cycle distribution and apoptosis.
• In vitro incubation of Ehrlich carcinoma cells with the complex.

Main Results:

• Injection of the complex led to regression of transplanted Ehrlich carcinoma.
• The complex disturbed tumor cell cycle distribution.
• Apoptosis was induced in approximately 34.3% of tumor cells.
• In vitro incubation showed no tumor cell death and slight proliferation increase.

Conclusions:

• The hemoglobin-containing serum protein complex demonstrates in vivo anti-cancer activity against Ehrlich carcinoma.
• The complex's mechanism involves inducing apoptosis and altering cell cycle progression.
• The in vitro results suggest the therapeutic effect is dependent on the in vivo environment.